Bicocca Open Archive

Logo unimib boa
BONFANTI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 22.017
NA - Nord America 20.326
EU - Europa 12.391
SA - Sud America 3.303
AF - Africa 504
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 6
Totale 58.581
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.296
SG - Singapore 7.620
VN - Vietnam 5.504
IT - Italia 3.738
HK - Hong Kong 2.952
CN - Cina 2.808
BR - Brasile 2.491
RU - Federazione Russa 2.129
DE - Germania 1.713
SE - Svezia 1.165
IE - Irlanda 964
CA - Canada 720
FR - Francia 556
GB - Regno Unito 531
ID - Indonesia 494
IN - India 491
BD - Bangladesh 357
KR - Corea 340
FI - Finlandia 327
AR - Argentina 310
NL - Olanda 259
IQ - Iraq 222
AT - Austria 211
MX - Messico 203
TR - Turchia 187
UA - Ucraina 178
ZA - Sudafrica 161
JP - Giappone 145
PK - Pakistan 145
ES - Italia 140
EC - Ecuador 126
PH - Filippine 118
PL - Polonia 117
SA - Arabia Saudita 93
CO - Colombia 88
UZ - Uzbekistan 77
VE - Venezuela 71
MY - Malesia 68
MA - Marocco 66
CL - Cile 62
RO - Romania 60
KE - Kenya 58
PY - Paraguay 58
CH - Svizzera 52
AE - Emirati Arabi Uniti 49
JO - Giordania 40
TH - Thailandia 37
EG - Egitto 36
LT - Lituania 36
KZ - Kazakistan 35
TN - Tunisia 32
PE - Perù 31
NP - Nepal 30
UY - Uruguay 30
BE - Belgio 29
BO - Bolivia 28
CZ - Repubblica Ceca 27
DZ - Algeria 27
ET - Etiopia 27
OM - Oman 27
PS - Palestinian Territory 27
AU - Australia 26
AL - Albania 22
GR - Grecia 20
IR - Iran 20
CR - Costa Rica 19
IL - Israele 17
BG - Bulgaria 16
JM - Giamaica 15
NG - Nigeria 15
TW - Taiwan 15
AZ - Azerbaigian 14
HN - Honduras 14
LB - Libano 14
SN - Senegal 14
PA - Panama 13
PT - Portogallo 12
DK - Danimarca 11
UG - Uganda 11
HU - Ungheria 10
KG - Kirghizistan 10
SY - Repubblica araba siriana 10
BH - Bahrain 9
BY - Bielorussia 9
DO - Repubblica Dominicana 9
GT - Guatemala 8
MD - Moldavia 8
TT - Trinidad e Tobago 8
NZ - Nuova Zelanda 7
RS - Serbia 7
SK - Slovacchia (Repubblica Slovacca) 7
AM - Armenia 6
AO - Angola 6
GE - Georgia 6
GH - Ghana 6
HR - Croazia 6
MU - Mauritius 6
NO - Norvegia 6
SC - Seychelles 6
BA - Bosnia-Erzegovina 5
Totale 58.462
Salva come PNG Salva come JPEG
Città #
Singapore 3.985
Hong Kong 2.697
Ann Arbor 2.463
Ashburn 1.828
Ho Chi Minh City 1.628
San Jose 1.533
Hanoi 1.374
Frankfurt am Main 1.253
Dublin 933
Milan 874
New York 864
Dallas 847
Fairfield 781
Chandler 748
Hefei 691
Santa Clara 646
Chicago 609
Los Angeles 596
Toronto 493
Wilmington 427
Woodbridge 406
Houston 398
The Dalles 397
Jakarta 388
Princeton 386
Beijing 357
Seoul 326
Seattle 318
Lauterbourg 310
Buffalo 259
Council Bluffs 228
Cambridge 225
Moscow 223
São Paulo 210
Altamura 206
Da Nang 189
Haiphong 182
Helsinki 180
Lawrence 179
Rome 171
Nuremberg 140
London 137
San Diego 121
Shanghai 119
Biên Hòa 115
Tokyo 115
Vienna 112
Dong Ket 109
Hải Dương 109
Munich 104
Orem 96
Ha Long 93
Quận Bình Thạnh 92
Rio de Janeiro 92
Warsaw 90
Johannesburg 89
Guangzhou 88
Lappeenranta 88
Jacksonville 86
Montreal 80
Ninh Bình 79
Baghdad 78
Can Tho 78
Thái Nguyên 74
Tashkent 73
Vũng Tàu 69
Atlanta 67
Denver 65
Brooklyn 64
Chennai 64
Kent 63
Amsterdam 62
Andover 61
Boardman 58
Bắc Ninh 57
Phoenix 57
Stockholm 56
Salt Lake City 55
Dearborn 54
Naples 53
Poplar 53
Mexico City 52
Pune 52
Belo Horizonte 49
Nairobi 48
San Francisco 48
Brasília 47
Dhaka 46
Monza 45
Quito 45
Boston 44
Falls Church 44
Lahore 44
Quận Một 44
Galati 43
Turin 43
Zurich 43
Istanbul 42
Bắc Giang 41
Phủ Lý 40
Totale 35.083
Salva come PNG Salva come JPEG
Nome #
PRESENTAZIONE DEL VADEMECUM DI SIMIT-LOMBARDIA, PER LE VACCINAZIONI DELL’ADULTO A RISCHIO PER CONDIZIONE O PATOLOGIA 661
Methotrexate inhibits SARS-CoV-2 virus replication "in vitro" 561
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 517
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levels 492
CNS relapse risk in HIV-positive patients affected by DLBCL and HGBL – a retrospective study of the musthal cohort 484
Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort 447
Cabotegravir-rilpivirine long-acting injectable regimen: an analysis of the causes of interruption and impact of genotypic drug resistance in a multicentric cohort 440
The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: A randomized multicentric study 440
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 390
Unexpected HBV reactivation following discontinuation of antiviral prophylaxis in immunosuppressed subjects with previous HBV exposure 387
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 386
Colistin-resistant Acinetobacter baumanii: a case series. 384
L’esposizione a Rilpivirina rappresenta un fattore di rischio per la progressione della steatosi epatica nelle persone con infezione da HIV. 365
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 364
A second update on mapping the human genetic architecture of COVID-19 362
What remains of long COVID after four years from hospitalization for severe COVID pneumonia 357
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 343
Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individuals 339
An immune-based biomarker signature is associated with mortality in COVID-19 patients 335
Mapping the human genetic architecture of COVID-19 334
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 319
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 319
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 319
Effectiveness of dolutegravir-based vs boosted darunavir-based first-line 3-drug regimens in people with HIV with advanced disease: a trial emulation 316
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study 315
Characteristics and Clinical Implications of Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection, Italy 315
Transaminase Decrease Upon Switch From TDF to TAF in PWH Is Modulated by HBV Status 306
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 305
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 304
Hepatitis B core antibody positivity is not associated with risk of transaminase elevation following switch to dual antiretroviral therapy 303
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 301
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 301
Hospital-Acquired Infections in Critically Ill Patients With COVID-19 299
Long-acting injectable antiretrovirals for HIV treatment in the ICONA cohort: physicians' and nurses' points of view 298
Infezione disseminata da Mycobacterium avium complex con batteriemia persistente in un paziente AIDS-presenter [Disseminated Mycobacterium avium complex infection with persistent bacteremia in an AIDS-presenter patient] 293
High rates of 30-day mortality in patients with cirrhosis and COVID-19 293
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 290
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 283
Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting 282
Association Between Sex Hormone Levels and Clinical Outcomes in Patients With COVID-19 Admitted to Hospital: An Observational, Retrospective, Cohort Study 281
Switch da Tenofovir disoproxil fumarato (TDF) a Tenofovir alafenamide (TAF) e aumento del colesterolo: impatto sulla valutazione del rischio cardiovascolare 280
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 280
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 272
Alternative pre-analytical strategies for SARS CoV 2 RNA detection 267
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 266
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 265
Delirium in Patients with SARS‐CoV‐2 Infection: A Multicenter Study 264
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 262
A multidisciplinary approach to screen the post-COVID-19 conditions 261
Ceftazidime-avibactam use for KPC-Kp infections: a retrospective observational multicenter study 256
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata 256
Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests 253
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 248
Ceftazidime-avibactam plus aztreonam versus cefiderocol in the treatment of infections caused by Metallo-β lactamase-Producing Microorganisms: real-word data from the Italian cohort SUSANA 248
Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort 247
Weight gain: A possible side effect of all antiretrovirals 247
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 247
Atrial Fibrillation Incidence in SARS-COV-2 Infected Patients: Predictors and Relationship with in-Hospital Mortality 245
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 244
Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona) 243
People with HIV pioneers of injectable cabotegravir and rilpivirine long acting in Italy: who are they? 241
Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment? 241
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 238
Insights on HIV infection, some reflecting after eight years of the Journal. 236
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study 234
Invecchiare con la terapia antiretrovirale o essere anziani in terapia antiretrovirale: due profili di comorbidità differenti? 234
HIV and metabolic syndrome - A comparison with the general population 233
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 233
The effect of frailty on in-hospital and medium-term mortality of patients with COronaVIrus Disease-19: the FRACOVID study 233
Steroids in severe COVID-19 patients: A retrospective analysis on the first pandemics in Lombardy 232
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 230
Auto-antibodies against type I IFNs in patients with life-threatening COVID-19 229
High-risk HPV genotypes are associated with anal cytologic abnormalities but not with malignant histological lesions in a cohort of people with HIV (PWH) 228
Incident Atrial Fibrillation and In-Hospital Mortality in SARS-CoV-2 Patients 225
First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006) 222
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 220
Disentangling the Association of Hydroxychloroquine Treatment with Mortality in Covid-19 Hospitalized Patients through Hierarchical Clustering 220
Anti-spike antibody level is associated with the risk of clinical progression among subjects hospitalized with COVID-19 pneumonia: results from a retrospective cohort study 215
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 215
One-year survival and Quality of Life of first wave COVID-19 invasively ventilated patients in Lombardy, Italy 214
Characteristics of long COVID after two years of follow-up in a previously hospitalized population 213
Stratified analyses refine association between TLR7 rare variants and severe COVID-19 210
Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infections 209
Awake Prone Positioning in Adults With COVID-19 An Individual Participant Data Meta-Analysis 209
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 208
Anti-SARS-CoV-2 IgG antibodies induced by the BNT162b2 mRNA vaccine is age-dependent and influenced by a previous natural SARS-CoV-2 infection 206
Long-term durability of dolutegravir + darunavir/cobicistat dual regimen in highly antiretroviral-experienced people living with HIV (DoDaco study) 205
Pillars of long-term antiretroviral therapy success 205
Beware of biases in observational studies on anti-spike monoclonal antibodies 205
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 202
Symptomatic neurocognitive impairmentassociated to CNS viral escape in an HIV-1 infected patient: a case report. 201
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 201
COVID-19 Mortality and Stress to the Hospital System From High Patient Load 201
Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024 200
Multiple concomitanti infezioni opportunistiche e linfomi aggressivi in una persona con HIV/AIDS che non assumeva la terapia ant 199
Symptom profile, case and symptom clustering, clinical and demographic characteristics of a multicentre cohort of 1297 patients evaluated for Long-COVID 199
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 198
Atrial fibrillation and clinical outcomes in a cohort of hospitalized patients with sars-cov-2 infection and chronic kidney disease 197
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 196
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohort 195
Totale 28.213
Salva come PNG Salva come JPEG
Categoria #
all - tutte 198.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 198.042
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021785 0 0 0 0 0 0 0 0 0 0 329 456
2021/20222.857 306 319 311 238 160 207 117 201 169 124 194 511
2022/20234.492 587 1.070 440 387 359 707 98 236 290 71 136 111
2023/20243.837 150 117 223 136 475 923 622 127 358 147 80 479
2024/202513.132 646 1.407 679 529 847 706 757 331 1.009 1.747 1.507 2.967
2025/202630.196 4.886 3.127 2.614 3.311 3.157 1.532 4.070 1.480 2.081 2.635 1.303 0
Totale 59.776